RDA Financial Network’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.78M | Buy |
4,399
+68
| +2% | +$27.6K | 0.48% | 60 |
|
2025
Q1 | $2.15M | Buy |
4,331
+28
| +0.7% | +$13.9K | 0.64% | 42 |
|
2024
Q4 | $2.24M | Buy |
4,303
+47
| +1% | +$24.5K | 0.65% | 39 |
|
2024
Q3 | $2.63M | Buy |
4,256
+167
| +4% | +$103K | 0.82% | 28 |
|
2024
Q2 | $2.26M | Buy |
4,089
+894
| +28% | +$494K | 0.74% | 36 |
|
2024
Q1 | $1.86M | Buy |
3,195
+169
| +6% | +$98.2K | 0.64% | 46 |
|
2023
Q4 | $1.61M | Buy |
3,026
+173
| +6% | +$91.8K | 0.61% | 47 |
|
2023
Q3 | $1.44M | Buy |
2,853
+81
| +3% | +$41K | 0.63% | 49 |
|
2023
Q2 | $1.45M | Sell |
2,772
-33
| -1% | -$17.2K | 0.61% | 50 |
|
2023
Q1 | $1.62M | Buy |
2,805
+16
| +0.6% | +$9.22K | 0.74% | 40 |
|
2022
Q4 | $1.54M | Sell |
2,789
-525
| -16% | -$289K | 0.77% | 38 |
|
2022
Q3 | $1.68M | Sell |
3,314
-63
| -2% | -$32K | 0.92% | 29 |
|
2022
Q2 | $1.84M | Sell |
3,377
-57
| -2% | -$31K | 0.93% | 30 |
|
2022
Q1 | $2.03M | Buy |
3,434
+696
| +25% | +$411K | 0.86% | 32 |
|
2021
Q4 | $1.83M | Buy |
2,738
+59
| +2% | +$39.4K | 0.75% | 40 |
|
2021
Q3 | $1.53M | Buy |
2,679
+103
| +4% | +$58.9K | 0.67% | 46 |
|
2021
Q2 | $1.3M | Buy |
2,576
+131
| +5% | +$66.1K | 0.57% | 53 |
|
2021
Q1 | $1.12M | Buy |
2,445
+318
| +15% | +$145K | 0.48% | 62 |
|
2020
Q4 | $991K | Buy |
+2,127
| New | +$991K | 0.45% | 61 |
|